Etanercept has been shown to protect against the in vivo lethal infection of mice with a highly virulent, mouse-adapted IAV strain (205), with observations made of an increased survival rate with decreased morbidity, expression of the proinflammatory cytokine IL-6, lung injury, and edema (205). Here, IL6 is linked to infection.